Jeffrey Alan Hovden
Jeffrey Alan HovdenPartner,
Robins Kaplan LLP

Jeffrey practices in the area of patent litigation, with a focus on generic pharmaceutical patent cases under the Hatch-Waxman Act and within the biotechnology industry. He has litigated numerous patent infringement and invalidity actions, including several cases involving top-selling worldwide prescription drugs for both generic and name-brand clients. He is experienced with copyrights, particularly those involving functional works. He counsels biotechnology clients regarding licensing matters and routinely advises clients on their intellectual property portfolios.

He has extensive experience with the Food, Drug, and Cosmetic Act’s drug-approval provisions and their attendant regulations. He also provides infringement, validity and due diligence opinions. In addition to this, he has given media interviews on a variety of topics related to the Hatch-Waxman litigation, both in print and on the radio.

© Copyright 2019 Legal Media Group. All Rights Reserved.